A detailed history of Third View Private Wealth, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Third View Private Wealth, LLC holds 2,830 shares of GKOS stock, worth $254,784. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,830
Holding current value
$254,784
% of portfolio
0.04%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 23, 2026

BUY
$74.67 - $92.61 $211,316 - $262,086
2,830 New
2,830 $320 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.29B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Third View Private Wealth, LLC Portfolio

Follow Third View Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Third View Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Third View Private Wealth, LLC with notifications on news.